US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist
  • 1.1400
  • -0.0500-4.20%
Close Jan 8 16:00 ET
  • 1.1300
  • -0.0100-0.88%
Post 19:18 ET
210.28MMarket Cap-1.36P/E (TTM)

Nektar Therapeutics Key Stats

Nektar Therapeutics Q3 2024 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
18.28M
24.12M
+5.84M
Beat Est.
-24.29%
-0.08%
+31.97%
EPS
-0.21
-0.18
+0.03
Beat Est.
+12.13%
+25.00%
+14.61%
Strong Buy

Jan 7, 2025

Nektar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 22.390M --
-- 2024/Q4 -- / 36.654M --
Nov 7, 2024 2024/Q3 24.124M / 18.280M --
Aug 8, 2024 2024/Q2 23.489M / 17.545M --
May 9, 2024 2024/Q1 21.639M / 15.342M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 22.390M--
--2024/Q4-- / 36.654M--
Nov 7, 20242024/Q324.124M / 18.280M--
Aug 8, 20242024/Q223.489M / 17.545M--
May 9, 20242024/Q121.639M / 15.342M--

Unlock Free Earnings Estimates

Nektar Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 7, 2025

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

No Data